Uncategorized

Bright’s current SVP of finance Jay Matushak is stepping up after current CFO Cathy Smith elected to leave the post to pursue a new opportunity, the company said Wednesday.

Clinisys today announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety.

The agency said on Wednesday that it needs additional time to parse through the 38,000 public comments it received in response to a proposal to reintroduce stricter limits around telehealth prescribing.

Las creencias estereotipadas y negativas hacia las personas mayores (estereotipos edadistas) están ampliamente extendidas en personas de todas las edades.   Un estudio reciente, realizado por investigadores de la Universidad Autónoma de Madrid (UAM), la Universidad Rey Juan Carl …

Descubren que un compuesto natural, presente en cantidades significativas en algunos vegetales, podría proteger al ovario de los efectos nocivos de las terapias antitumorales. Este compuesto es el resveratrol, un producto de venta libre que ya se utiliza con otros fines terapéuticos. S …

Se ha conseguido detectar, por vez primera, las huellas dejadas por la explosión de algunas de las primeras estrellas que se formaron en el universo.   Utilizando el conjunto de telescopios VLT (Very Large Telescope) del Observatorio Europeo Austral (ESO), un equipo de investigadoras e …

Uno de los conjuntos de radiotelescopios más potentes del mundo se une a la caza de señales procedentes de posibles civilizaciones alienígenas en nuestra galaxia. El conjunto de radiotelescopios VLA (Karl G. Jansky Very Large Array), de la Fundación Nacional de Ciencia (N …

Soligenix, Inc. announced today positive clinical results from a compatibility study evaluating HyBryte™ (synthetic hypericin sodium) in the treatment of cutaneous T-cell lymphoma (CTCL) using the commercially ready Daavlin Series 7 visible light device, which recently received 510(k) clearance from U.S. Food and Drug Administration (FDA).

Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), today announced that Thomas Sandgaard , its Chief Executive Officer (the “Selling Stockholder”), has determined not to pursue the public offering of 2,000,000 shares of the Company’s common stock that was previously announced on May 3, 2023 (the “Secondary Offering”).

NuVasive, Inc. announced today the Company will release its first quarter 2023 results on Wednesday, May 10, 2023, after the close of the market.